Eva Barnett
Förmögenhet: 6 M $ per 2026-07-31
Förmögenhet: 6 M $ per 2026-07-31
Eva Renee Barnett worked at Eli Lilly & Co. from 2011 to 2012 as Chief Financial Officer-Austria & Switzerland.
From 2015 to 2021, worked at AbleTo, Inc. as Chief Integration Officer.
From 2021 to 2025, worked at Immunovant, Inc. as Chief Financial & Accounting Officer.
Education includes undergraduate studies at DePauw University and an MBA from Harvard Business School.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
IMMUNOVANT INC 0,08 % | 2026-06-30 | 157 761 ( 0,08 % ) | 6 M $ | 2026-07-31 |
| Företag | Position | Slut |
|---|---|---|
| IMMUNOVANT, INC. | Finansdirektör/CFO | 2025-04-20 |
AbleTo, Inc.
AbleTo, Inc. Medical/Nursing ServicesHealth Services Provides online therapy and coaching services for mental health conditions | Finansdirektör/CFO | 2018-03-01 |
| ELI LILLY AND COMPANY | Företagsledare/Principal | 2012-08-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
AbleTo, Inc.
AbleTo, Inc. Medical/Nursing ServicesHealth Services Provides online therapy and coaching services for mental health conditions | Health Services |
DePauw University
DePauw University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunovant, Inc.
Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån